NIH-funded research R01 grant

The impact of uremic toxins on heart disease in kidney patients

Official title: Uremic Toxins and Cardiovascular Disease

Funded at Indiana University Indianapolis · NIH-10878531 · Data updated 2026-11-12

This study is looking at how certain harmful substances that build up in people with chronic kidney disease can affect heart health, and it aims to find out if changing what you eat can help improve heart function and reduce risks for heart problems.

More Cardiovascular Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIndiana University Indianapolis
NIH-funded
Lab location1 site (Indianapolis, United States)
Project startAugust 1, 2024
Project endJuly 31, 2028
Funding year2024
Award (this year)$718,091
NIH project number1R01HL170142-01A1
Project IDNIH-10878531 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who have chronic kidney disease.

Less likely to help

Patients without chronic kidney disease or those with early-stage kidney disease may not benefit from this research.

What this research studies

This research investigates how uremic toxins, which accumulate in patients with chronic kidney disease (CKD), contribute to cardiovascular disease (CVD). It focuses on understanding the mechanisms by which these toxins, such as indoxyl sulfate, affect heart function and structure, particularly leading to conditions like left ventricular hypertrophy and arrhythmias. The study utilizes a rat model that mimics advanced human CKD to explore the effects of dietary interventions on toxin levels and heart health. By identifying non-traditional risk factors for CVD in CKD patients, the research aims to improve risk assessment and treatment strategies.

Why it matters

Potential benefit: If successful, this research could lead to better prevention and treatment strategies for heart disease in patients with chronic kidney disease.

How similar studies have gone: Previous research has shown that addressing uremic toxins can improve cardiovascular outcomes in CKD patients, suggesting a promising avenue for further exploration.

Where this research is happening

  • Indiana University Indianapolis
    Indianapolis, United States
    Active

Researchers

  • Principal investigator: Moe, Sharon M — Indiana University Indianapolis
  • Study coordinator: Moe, Sharon M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.